Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

Journal of Experimental Medicine

Volumn 186, Issue 7, 1997, Pages 1177-1182

  Ashley, David M ^a   Faiola, Brenda ^a   Nair, Smita ^a   Hale, Laura P ^a   Bigner, Darell D ^a   Gilboa, Eli ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RNA; TUMOR VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; VACCINATION;

ANIMALS; BONE MARROW CELLS; CANCER VACCINES; CELL EXTRACTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DENDRITIC CELLS; HISTOCYTOCHEMISTRY; IMMUNOTHERAPY; MELANOMA, EXPERIMENTAL; MICE; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030808677     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.7.1177     Document Type: Article

References (25)

1. Grooms, G.A., F.R. Eilber, and D.L. Morton. 1977. Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients. J. Surg. Oncol. 9:147-153.
2. Mitchell, M.S. 1989. Relapse in the central nervous system in melanoma patients successfully treated with biomodulators. J. Clin. Oncol. 7:1701-1709.
3. Fakhrai, H., O. Dorigo, D.L. Shawler, H. Lin, D. Mercola, K.L. Black, I. Royston, and R.E. Sobol. 1996. Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc. Natl. Acad. Sci. USA. 93:2909-2914.
4. + cell mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. USA. 93:10399-10404.
5. Bigner, D.D., O.M. Pitts, and C.J. Wikstrand. 1981. Induction of lethal experimental allergic encephalomyelitis in non-human primates and guinea pigs with human glioblastoma multiforme tissue. J. Neurosurg. 55:32-42.
6. Dillman, R.O., S.K. Nayak, and L. Beutel. 1993. Establishing in vitro cultures of autologous tumor cells for use in active specific immunotherapy. J. Immunother. 14:65-69.
7. Logan, T.F., W. Shannon, J. Bryant, P. Kane, N. Wolmark, M. Posner, J.M. Kirkwood, M.S. Ernstoff, J.W. Futrell, L.D. Straw, et al. 1993. Preparation of viable tumor cell vaccine from human solid tumours: relationship between tumour mass and cell yield. Melanoma Res. 3:451-455.
8. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918-2926.
9. Paglia, P., C. Chiodoni, M. Rodolfo, and M.P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317-322.
10. Celluzzi, C.M., J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
11. Boon, T., J.C. Cerottini, and B. Van den Eynde. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
12. Nair, S.K., D. Boczkowski, D. Snyder, and E. Gilboa. 1997. Antigen-presenting cells pulsed with tumor unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol. 27:589-597.
13. Zitvogel, L., J.I. Mayordomo, T. Tjandrawan, A.B. DeLeo, M.R. Clarke, M.T. Lotze, and W.J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87-97.
14. Nair, S.K., D. Snyder, B.T. Rouse, and E. Gilboa. 1997. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int. J. Cancer. 70:706-715.
15. Boczkowski, D., S.K. Nair, D. Snyder, and E. Gilboa. 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465-472.
16. Fidler, I.J. 1975. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35:218-224.
17. Serano, R.D., C.N. Pegram, and D.D. Bigner. 1980. Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol. 51:53-64.
18. Kurtzberg, J., and M.S. Hershfield. 1985. Determinants of deoxyadenosine toxicity in hybrids between human T-and B-lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Cancer Res. 45: 1579-1586.
19. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182: 255-260.
20. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
21. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R.C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90: 3539-3543.
22. Ashley, D.M., J.H. Sampson, G.E. Archer, S.K. Batra, D.D. Bigner, and L.P. Hale. 1997. A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo. J. Neuroimmunol. In press.
23. Kaplan, E.L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53:457-481.
24. Gilboa, E., H.K. Lyerly, J. Vieweg, and S. Saito. 1994. Immunotherapy of cancer using cytokine gene-modified tumor vaccines. Semin. Cancer Biol. 5:409-417.
25. Porgador, A., E. Tzehoval, E. Vadai, M. Feldman, and L. Eisenbach. 1993. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-γ genes. J. Immunother. 14: 191-201.